Hudson Bay Capital Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-536,275
Closed -$16M 1512
2025
Q3
$16M Buy
536,275
+136,275
+34% +$4.55M 0.05% 264
2025
Q2
$11.9M Sell
400,000
-64,969
-14% -$1.87M 0.04% 320
2025
Q1
$14.2M Buy
464,969
+164,969
+55% +$5.55M 0.04% 321
2024
Q4
$11.9M Buy
+300,000
New +$11.7M 0.04% 328

Other funds holding SRDX

Hudson Bay Capital Management's SRDX Position: Q4 2025 in Review

Hudson Bay Capital Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 536,275 shares — an estimated $16M sold.

Hudson Bay Capital Management first reported a position in SRDX in Q4 2024 and held it in 4 quarters. The position peaked at $16M in Q3 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Hudson Bay Capital Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 536,275 Surmodics shares in Q4 2025, an estimated $16M.
  • Hudson Bay Capital Management first reported a position in Surmodics in Q4 2024 and held it in 4 quarters.
  • Hudson Bay Capital Management's Surmodics position peaked at $16M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Hudson Bay Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.